vs
Niagen Bioscience, Inc.（NAGE）与RBB Bancorp（RBB）财务数据对比。点击上方公司名可切换其他公司
Niagen Bioscience, Inc.的季度营收约是RBB Bancorp的1.0倍（$33.8M vs $32.3M），RBB Bancorp净利率更高（31.5% vs 12.2%，领先19.3%），Niagen Bioscience, Inc.同比增速更快（16.2% vs 12.6%），过去两年Niagen Bioscience, Inc.的营收复合增速更高（23.6% vs 7.0%）
Niagen Bioscience（原名为ChromaDex）是一家成立于1999年，总部位于加利福尼亚州洛杉矶的生物科技公司。公司业务涵盖标准品、膳食补充剂以及原料技术开发多个领域，目前在纳斯达克挂牌上市。
RBB银行控股公司是总部位于美国的金融控股集团，旗下核心主体为皇家商业银行，主要服务亚裔社群、中小微企业、不动产投资者及零售客户，提供商业信贷、储蓄存款、财富管理等多元金融服务，业务覆盖美国沿海核心都会区。
NAGE vs RBB — 直观对比
营收规模更大
NAGE
是对方的1.0倍
$32.3M
营收增速更快
NAGE
高出3.6%
12.6%
净利率更高
RBB
高出19.3%
12.2%
两年增速更快
NAGE
近两年复合增速
7.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $33.8M | $32.3M |
| 净利润 | $4.1M | $10.2M |
| 毛利率 | 64.1% | — |
| 营业利润率 | 12.1% | 39.5% |
| 净利率 | 12.2% | 31.5% |
| 营收同比 | 16.2% | 12.6% |
| 净利润同比 | -42.4% | 132.1% |
| 每股收益（稀释后） | $0.05 | $0.59 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NAGERBB
| Q4 25 | $33.8M | $32.3M | ||
| Q3 25 | $34.0M | $32.6M | ||
| Q2 25 | $31.1M | $35.8M | ||
| Q1 25 | $30.5M | $28.5M | ||
| Q4 24 | $29.1M | $28.7M | ||
| Q3 24 | $25.6M | $30.3M | ||
| Q2 24 | $22.7M | $27.5M | ||
| Q1 24 | $22.2M | $28.2M |
净利润NAGERBB
| Q4 25 | $4.1M | $10.2M | ||
| Q3 25 | $4.6M | $10.1M | ||
| Q2 25 | $3.6M | $9.3M | ||
| Q1 25 | $5.1M | $2.3M | ||
| Q4 24 | $7.2M | $4.4M | ||
| Q3 24 | $1.9M | $7.0M | ||
| Q2 24 | $-15.0K | $7.2M | ||
| Q1 24 | $-492.0K | $8.0M |
毛利率NAGERBB
| Q4 25 | 64.1% | — | ||
| Q3 25 | 64.5% | — | ||
| Q2 25 | 65.0% | — | ||
| Q1 25 | 63.4% | — | ||
| Q4 24 | 62.5% | — | ||
| Q3 24 | 63.5% | — | ||
| Q2 24 | 60.2% | — | ||
| Q1 24 | 60.7% | — |
营业利润率NAGERBB
| Q4 25 | 12.1% | 39.5% | ||
| Q3 25 | 12.5% | 40.7% | ||
| Q2 25 | 10.2% | 36.1% | ||
| Q1 25 | 15.7% | 11.2% | ||
| Q4 24 | 24.4% | 17.6% | ||
| Q3 24 | 6.3% | 31.6% | ||
| Q2 24 | -1.1% | 35.6% | ||
| Q1 24 | -3.3% | 39.9% |
净利率NAGERBB
| Q4 25 | 12.2% | 31.5% | ||
| Q3 25 | 13.5% | 31.2% | ||
| Q2 25 | 11.6% | 26.1% | ||
| Q1 25 | 16.6% | 8.0% | ||
| Q4 24 | 24.6% | 15.3% | ||
| Q3 24 | 7.3% | 23.1% | ||
| Q2 24 | -0.1% | 26.4% | ||
| Q1 24 | -2.2% | 28.4% |
每股收益（稀释后）NAGERBB
| Q4 25 | $0.05 | $0.59 | ||
| Q3 25 | $0.05 | $0.59 | ||
| Q2 25 | $0.04 | $0.52 | ||
| Q1 25 | $0.06 | $0.13 | ||
| Q4 24 | $0.10 | $0.26 | ||
| Q3 24 | $0.02 | $0.39 | ||
| Q2 24 | $0.00 | $0.39 | ||
| Q1 24 | $-0.01 | $0.43 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $212.3M |
| 总债务越低越好 | — | $119.9M |
| 股东权益账面价值 | $76.5M | $523.4M |
| 总资产 | $106.4M | $4.2B |
| 负债/权益比越低杠杆越低 | — | 0.23× |
8季度趋势，按日历期对齐
现金及短期投资NAGERBB
| Q4 25 | — | $212.3M | ||
| Q3 25 | $64.1M | $234.9M | ||
| Q2 25 | $60.3M | $191.9M | ||
| Q1 25 | $55.5M | $238.8M | ||
| Q4 24 | $44.5M | $257.7M | ||
| Q3 24 | $32.2M | $349.4M | ||
| Q2 24 | $27.7M | $252.8M | ||
| Q1 24 | $27.4M | — |
总债务NAGERBB
| Q4 25 | — | $119.9M | ||
| Q3 25 | — | $119.8M | ||
| Q2 25 | — | $119.7M | ||
| Q1 25 | — | $119.6M | ||
| Q4 24 | — | $119.5M | ||
| Q3 24 | — | $119.4M | ||
| Q2 24 | — | $119.3M | ||
| Q1 24 | — | $119.2M |
股东权益NAGERBB
| Q4 25 | $76.5M | $523.4M | ||
| Q3 25 | $70.7M | $514.3M | ||
| Q2 25 | $64.2M | $517.7M | ||
| Q1 25 | $55.3M | $510.3M | ||
| Q4 24 | $46.1M | $507.9M | ||
| Q3 24 | $34.4M | $509.7M | ||
| Q2 24 | $30.7M | $511.3M | ||
| Q1 24 | $29.0M | $514.0M |
总资产NAGERBB
| Q4 25 | $106.4M | $4.2B | ||
| Q3 25 | $98.1M | $4.2B | ||
| Q2 25 | $91.5M | $4.1B | ||
| Q1 25 | $81.3M | $4.0B | ||
| Q4 24 | $68.3M | $4.0B | ||
| Q3 24 | $56.5M | $4.0B | ||
| Q2 24 | $54.0M | $3.9B | ||
| Q1 24 | $54.1M | $3.9B |
负债/权益比NAGERBB
| Q4 25 | — | 0.23× | ||
| Q3 25 | — | 0.23× | ||
| Q2 25 | — | 0.23× | ||
| Q1 25 | — | 0.23× | ||
| Q4 24 | — | 0.24× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.23× | ||
| Q1 24 | — | 0.23× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $679.0K | $43.4M |
| 自由现金流经营现金流 - 资本支出 | — | $42.6M |
| 自由现金流率自由现金流/营收 | — | 131.8% |
| 资本支出强度资本支出/营收 | — | 2.5% |
| 现金转化率经营现金流/净利润 | 0.16× | 4.26× |
| 过去12个月自由现金流最近4个季度 | — | $73.5M |
8季度趋势，按日历期对齐
经营现金流NAGERBB
| Q4 25 | $679.0K | $43.4M | ||
| Q3 25 | $3.7M | $2.1M | ||
| Q2 25 | $1.3M | $21.7M | ||
| Q1 25 | $7.9M | $7.8M | ||
| Q4 24 | $8.6M | $58.5M | ||
| Q3 24 | $3.5M | $24.5M | ||
| Q2 24 | $-264.0K | $11.7M | ||
| Q1 24 | $295.0K | $4.8M |
自由现金流NAGERBB
| Q4 25 | — | $42.6M | ||
| Q3 25 | — | $1.8M | ||
| Q2 25 | — | $21.6M | ||
| Q1 25 | — | $7.6M | ||
| Q4 24 | — | $57.7M | ||
| Q3 24 | — | $24.2M | ||
| Q2 24 | — | $11.5M | ||
| Q1 24 | — | $4.7M |
自由现金流率NAGERBB
| Q4 25 | — | 131.8% | ||
| Q3 25 | — | 5.4% | ||
| Q2 25 | — | 60.2% | ||
| Q1 25 | — | 26.7% | ||
| Q4 24 | — | 201.0% | ||
| Q3 24 | — | 80.0% | ||
| Q2 24 | — | 42.0% | ||
| Q1 24 | — | 16.6% |
资本支出强度NAGERBB
| Q4 25 | — | 2.5% | ||
| Q3 25 | — | 1.1% | ||
| Q2 25 | — | 0.3% | ||
| Q1 25 | — | 0.6% | ||
| Q4 24 | — | 2.7% | ||
| Q3 24 | — | 0.8% | ||
| Q2 24 | — | 0.5% | ||
| Q1 24 | — | 0.5% |
现金转化率NAGERBB
| Q4 25 | 0.16× | 4.26× | ||
| Q3 25 | 0.81× | 0.21× | ||
| Q2 25 | 0.35× | 2.32× | ||
| Q1 25 | 1.56× | 3.39× | ||
| Q4 24 | 1.20× | 13.34× | ||
| Q3 24 | 1.86× | 3.50× | ||
| Q2 24 | — | 1.61× | ||
| Q1 24 | — | 0.60× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NAGE
| TRUNIAGEN Consumer Product | $27.5M | 81% |
| Ingredients Segment | $5.7M | 17% |
| Other | $694.0K | 2% |
RBB
暂无分部数据
